Protagonist Therapeutics, Inc. (PTGX)

84.98 +3.62 (+4.45%) USD  |  NASDAQ  |  Jan 14, 15:43
More

Protagonist Therapeutics Rent and Landing Expense (Quarterly)

Rent and Landing Expense (Quarterly) Chart

View Rent and Landing Expense (Quarterly) for PTGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Rent and Landing Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Rent and Landing Expense (Quarterly) Range, Past 5 Years

View Rent and Landing Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Rent and Landing Expense (Quarterly) Benchmarks

View Rent and Landing Expense (Quarterly) Benchmarks
Start Trial
Johnson & Johnson --
ADMA Biologics, Inc. Upgrade
Bristol Myers Squibb Co. --
MannKind Corp. Upgrade
Regeneron Pharmaceuticals, Inc. --